According to a survey of more than 1,200 licensed psychologists released by the American Psychological Association on June 16, 2026, 77% of psychologists have spoken with patients who used AI for support, engagement, or other reasons — and 39% have had patients use AI to self-diagnose a mental health condition. This isn't a fringe behavior anymore. It's a presenting issue that belongs in your clinical assessment, right alongside sleep, substance use, and social support.
---
What the APA's Data Actually Shows
The APA's 2026 report, Chatbots and Mental Health 2026, surveyed licensed psychologists across the U.S. who work directly with clients or patients. The numbers are worth sitting with.
39% of psychologists have had patients who said they used AI to self-diagnose a mental health condition. AI chatbots are not diagnostic instruments. They are not trained on validated psychological assessments and carry no accountability when they get it wrong. But a client who types their symptoms into ChatGPT at 1 a.m. and gets an answer that sounds confident doesn't know that. They show up to your next session with a working theory — and sometimes with a label they've already started organizing their identity around.
35% of psychologists report that their patients are using AI as an "additional mental health professional." That's a client who may be processing the same material with you on Tuesday and with a chatbot on Thursday — with no coordination, no documentation, and no clinical oversight on the other side of that conversation.
34% say their patients use AI for self-discipline, affirmations, or behavioral reminders. This is the least alarming use — and also the one where the research offers the most signal. Chatbot-based CBT support has peer-reviewed efficacy data for adjunctive use. But "adjunctive" is the operative word. When a clinician doesn't know this is happening, they can't integrate it, contextualize it, or catch the cases where the chatbot is doing something that cuts against the work.
The survey also found that 94% of psychologists believe today's chatbots cannot treat mental health conditions with the appropriate level of nuance, and 97% say chatbots may inadvertently reinforce negative behaviors or delusional beliefs. The concern isn't hypothetical. The APA pointed to documented cases where AI chatbots failed to recognize suicidal thinking, gave clinically inaccurate information with high confidence, and reinforced existing cognitive distortions by being — in the words of one expert — "affirming to a fault."
---
This Is a Clinical Issue, Not a Tech Opinion
The instinct to treat AI chatbot use as a patient education problem — "let me explain why ChatGPT isn't a therapist" — misses the clinical weight of what's happening.
A paper published in JAMA Psychiatry in April 2026 by Shaddy Saba, an assistant professor at NYU's Silver School of Social Work, argues that a patient's relationship with an AI chatbot carries real diagnostic and therapeutic weight that clinicians are currently not assessing. Saba and co-author William Weeks make the case that AI use belongs on the clinical intake form — not as a technology screening item, but as a clinical one.
Their reasoning: the content of what a client is discussing with an AI, the frequency of use, and whether the chatbot is reinforcing or undermining the therapeutic frame all matter. A client who uses an AI chatbot to journal thoughts between sessions is different from a client who uses one to get reassurance that their relationship is fine (and gets it, repeatedly, sycophantically), or to push back against something the therapist said in session. These are clinically distinct situations, and they're currently invisible because we don't ask.
The APA made the same argument in a guidance document released alongside the 2026 report: proactively asking about AI chatbot use is now a recommended clinical practice. Not as a judgment ("I don't want you using that"), but as an assessment ("Tell me more about that — what are you using it for, and how often?").
---
What to Actually Ask — and What to Do With the Answer
Clinical social workers and therapists don't need a new protocol. They need a new question, and a frame for what the answer tells them.
The question: "Some clients I work with are using AI chatbots — things like ChatGPT, or mental health apps — between sessions. Has that been something you've tried?"
That phrasing matters. It normalizes the behavior first (which it is — 77% of psychologists are seeing it), uses curiosity rather than judgment, and opens the door without implying the answer is wrong.
What the answer tells you:
If a client says no, note it and revisit it periodically. Usage is growing, and a client who said no in January may answer differently in August.
If a client says yes, the clinical follow-up isn't a lecture about AI limitations. It's an intake conversation: - What are they using it for? (Processing, information-seeking, companionship, reassurance, diagnosis?) - How often, and at what times? (Daily journaling is different from 3 a.m. crisis use.) - What have they found helpful or unhelpful about it? - Has anything the AI said surprised them, confused them, or conflicted with something you've worked on together?
That last question is where the clinical material lives. A client who says "it told me my anxiety is probably PTSD" — or "it told me my therapist is wrong about this" — is handing you something important about how they're processing the therapeutic relationship.
Documenting it: The JAMA Psychiatry paper recommends treating AI use the way you would other adjunctive self-help behaviors — note it in the initial assessment, revisit it when it becomes clinically relevant, and flag it in your treatment plan if it's affecting the work. There's no established state-specific documentation standard for this in New York, New Jersey, or Connecticut yet, but that doesn't mean the clinical record shouldn't reflect it. If something your client is doing between sessions is affecting your work together, it belongs in the record.
---
The Research Picture on AI Chatbot Safety
The clinical caution here isn't technophobia. It's based on what the research actually says.
A March 2025 randomized controlled trial published in NEJM AI — the Dartmouth Therabot study — found meaningful reductions in depression (51%), anxiety (31%), and eating disorder symptoms (19%) among participants using a highly supervised, expert-fine-tuned AI chatbot. That's a rigorous study, and the results are real. The study also involved substantial clinical oversight, a population with clinically significant symptoms, and a research model that bears little resemblance to what a client opens at midnight on their phone.
The APA's November 2025 health advisory on generative AI chatbots was more direct: these tools "cannot accurately assess risk or understand the nuance of someone's history, environment, or symptoms," and have "repeatedly failed to recognize or appropriately handle situations involving suicidal thoughts, self-harm, or acute distress." The advisory recommends clinicians proactively ask patients about their AI chatbot and wellness app use.
The gap between the Dartmouth study and the APA advisory is where your clinical judgment operates. AI tools used in clinical settings, with oversight, with appropriate populations, can show real benefit. AI tools used by clients without context, without a clinician who knows their history — that's a different situation, and an unassessed one.
---
The System Isn't Built for This Yet
Your EHR probably has no field for "patient AI chatbot use." Your intake paperwork almost certainly doesn't ask about it. The insurance companies whose prior auth processes still can't treat behavioral health as equivalent to medical care are not going to fund extra assessment time for this. The documentation burden is already real — and the administrative infrastructure for integrating AI use into clinical records doesn't exist yet.
What this means practically: the responsibility for assessing and documenting client AI use lands on you, without system-level support, without clear billing codes, and without a standardized framework from your licensing board. That's the familiar shape of being a behavioral health clinician in 2026. The system will catch up. It always does, slowly, after the clinicians on the ground have already figured out what to do.
Adding one question to your intake, building a shorthand into your notes, and treating AI use as a clinical variable rather than a technology curiosity — that's work you can do right now, with the tools you already have.
VibeCheck is built by a clinician who does this work, for clinicians being asked to do more of it without more infrastructure. The platform is designed to keep your clinical record clean and your administrative load manageable, so the time you have with a client stays focused on the actual work.
---
FAQ
Should I put AI chatbot use on my intake form?
Yes, if you're seeing it come up in sessions. A paper published in JAMA Psychiatry in April 2026 recommends treating it like other behavioral health history items — similar to asking about sleep, exercise, or social media use. The question doesn't have to be lengthy; it just has to open the door.
What do I do if a client has self-diagnosed using AI?
Treat it as clinical information, not a battle to win. Ask what they found, what resonated, and what led them to search in the first place. That context often tells you more about the presenting concern than the AI's output does. Then assess with validated tools if there's a genuine diagnostic question. The client's AI-generated hypothesis is a starting point for the clinical conversation, not the end of it.
Is AI chatbot use between sessions harmful?
It depends on how it's being used. Research on structured, CBT-based chatbot tools shows adjunctive benefit for some populations. Unmoderated, general-purpose AI chatbots carry real risks — they can reinforce cognitive distortions, fail to recognize crisis states, and generate confident-sounding clinical information that is inaccurate. The APA's 2026 survey found 97% of psychologists believe today's chatbots may reinforce negative behaviors. The answer isn't blanket prohibition; it's clinical assessment of what the client is using, when, and why.
Are there documentation standards for client AI use in New York, New Jersey, or Connecticut?
Not yet. No state licensing board in the tri-state area has issued specific documentation requirements for client AI chatbot use as of June 2026. That doesn't mean it's clinically irrelevant — it means the standard is being set by clinicians who are paying attention to it. If AI use is affecting the therapeutic work, it belongs in the clinical record.
---